Standardized mixed-meal tolerance and arginine stimulation tests provide reproducible and complementary measures of β-cell function: Results from the foundation for the national institutes of health biomarkers consortium investigative series

Diabetes Care

Volumn 39, Issue 9, 2016, Pages 1602-1613

  Shankar, Sudha S ^a   Vella, Adrian ^b   Raymond, Ralph H ^c   Staten, Myrlene A ^d   Calle, Roberto A ^e   Bergman, Richard N ^f   Cao, Charlie ^g   Chen, Danny ^e   Cobelli, Claudio ^h   Man, Chiara Dalla ^h   Deeg, Mark ^a   Dong, Jennifer Q ^e   Lee, Douglas S ^e   Polidori, David ⁱ   Robertson, R Paul ^j,k   Ruetten, Hartmut ^l   Stefanovski, Darko ^m   Vassileva, Maria T ⁿ   Weir, Gordon C ^o   Fryburg, David A ^p  

^a ELI LILLY AND COMPANY   (United States)

^b MAYO CLINIC   (United States)

^c R Squared Solutions   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e PFIZER INC   (United States)

^f CEDARS SINAI MEDICAL CENTER   (United States)

^g TAKEDA DEVELOPMENT CENTER AMERICAS   (United States)

^h UNIVERSITY OF PADOVA   (Italy)

ⁱ JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^j PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

^k UNIVERSITY OF WASHINGTON   (United States)

^l SANOFI   (France)

^m UNIVERSITY OF PENNSYLVANIA   (United States)

ⁿ NATIONAL INSTITUTES OF HEALTH   (United States)

^o JOSLIN DIABETES CENTER   (United States)

^p ROI BioPharma Consulting   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; C PEPTIDE; GLUCOSE; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; ARGININE STIMULATION TEST; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE PANCREAS FUNCTION TEST; FEMALE; GLUCAGON STIMULATION TEST; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; HYPERGLYCEMIC CLAMP TECHNIQUE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; MIXED MEAL TOLERANCE TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION DISTRIBUTION; PROTEIN BLOOD LEVEL; REPRODUCIBILITY; STANDARDIZATION; CASE CONTROL STUDY; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; MEAL; METABOLISM; MIDDLE AGED; NATIONAL HEALTH ORGANIZATION; PANCREAS ISLET BETA CELL; PREDIABETIC STATE; SECRETION (PROCESS); STANDARD; UNITED STATES;

ADULT; ARGININE; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MEALS; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH (U.S.); PREDIABETIC STATE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 84986183089     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-0931     Document Type: Article

References (44)

1. Sathananthan A, Dalla Man C, Zinsmeister AR, et al. A concerted decline in insulin secretion and action occurs across the spectrumof fasting and postchallenge glucose concentrations. Clin Endocrinol (Oxf) 2012;76:212-219
2. Bergman RN. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 1989;38:1512-1527
3. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
4. Cersosimo E, Solis-Herrera C, Trautmann ME, Malloy J, Triplitt CL. Assessment of pancreatic b-cell function: Review of methods and clinical applications. Curr Diabetes Rev 2014;10:2-42
5. Marena S,Montegrosso G, De Michieli F, Pisu E, Pagano G. Comparison of the metabolic effects of mixed meal and standard oral glucose tolerance test on glucose, insulin and C-peptide response in healthy, impaired glucose tolerance, mild and severe non-insulin-dependent diabetic subjects. Acta Diabetol 1992;29:29-33
6. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: Advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008;294:E15-E26
7. Pisprasert V, Ingram KH, Lopez-Davila MF, Munoz AJ, Garvey WT. Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: Impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care 2013;36:845-853
8. Selimoglu H, Duran C, Kiyici S, et al. Comparison of composite whole body insulin sensitivity index derived from mixed meal test and oral glucose tolerance test in insulin resistant obese subjects. Endocrine 2009;36:299-304
9. Wolever TM, Chiasson JL, Csima A, et al. Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed testmeal versus 75 g oral glucose.Diabetes Care 1998;21:336-340
10. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: Measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981;68:1456-1467
11. Cobelli C, Dalla Man C, Toffolo G, Basu R, Vella A, Rizza R. The oral minimal model method. Diabetes 2014;63:1203-1213
12. Nesher R, Cerasi E. Modeling phasic insulin release: Immediate and time-dependent effects of glucose. Diabetes 2002;51(Suppl. 1):S53-S59
13. Caumo A, Luzi L. First-phase insulin secretion: Does it exist in real life? Considerations on shape and function. Am J Physiol Endocrinol Metab 2004;287:E371-E385
14. Xiang AH, Watanabe RM, Buchanan TA. HOMA and Matsuda indices of insulin sensitivity: Poor correlation with minimal model-based estimates of insulin sensitivity in longitudinal settings. Diabetologia 2014;57:334-338
15. Toschi E, Camastra S, Sironi AM, et al. Effect of acute hyperglycemia on insulin secretion in humans. Diabetes 2002;51(Suppl. 1):S130-S133
16. Robertson RP, Raymond RH, Lee DS, et al.; Beta Cell Project Teamof the Foundation for the NIH Biomarkers Consortium. Arginine is preferred to glucagon for stimulation testing of b-cell function. Am J Physiol Endocrinol Metab 2014;307:E720-E727
17. Robertson RP, Bogachus LD, Oseid E, et al. Assessment of b-cell mass and a- and b-cell survival and function by arginine stimulation in human autologous islet recipients. Diabetes 2015;64:565-572
18. Teuscher AU, Kendall DM, Smets YF, Leone JP, Sutherland DE, Robertson RP. Successful islet autotransplantation in humans: Functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes 1998;47:324-330
19. Derosa G, Carbone A, Franzetti I, et al. Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, b-cell function and insulin resistance in type 2 diabetic patients. Diabetes Res Clin Pract 2012;98:51-60
20. Derosa G, Franzetti IG, Querci F, et al. Exenatide plus metformin compared with metformin alone on b-cell function in patients with Type 2 diabetes. Diabet Med 2012;29:1515-1523
21. Derosa G, Ragonesi PD, Carbone A, et al. Vildagliptin added to metformin on b-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patients. Diabetes Technol Ther 2012;14:475-484
22. Dalla Man C, Caumo A, Cobelli C. The oral glucose minimal model: Estimation of insulin sensitivity from a meal test. IEEE Trans Biomed Eng 2002;49:419-429
23. Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C. Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes 2001;50:150-158
24. Van Cauter E, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 1992;41:368-377
25. Koch GG, Amara IA, Davis GW, Gillings DB. A review of some statistical methods for covariance analysis of categorical data. Biometrics 1982;38:563-595
26. Basu A, Dalla Man C, Basu R, Toffolo G, Cobelli C, Rizza RA. Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism. Diabetes Care 2009;32:866-872
27. Bock G, Dalla Man C, Campioni M, et al. Pathogenesis of pre-diabetes: Mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 2006;55: 3536-3549
28. Smushkin G, Sathananthan M, Piccinini F, et al. The effect of a bile acid sequestrant on glucose metabolism in subjects with type 2 diabetes. Diabetes 2013;62:1094-1101
29. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: A new analysis. J Clin Endocrinol Metab 2005;90: 493-500
30. Kjems LL, Holst JJ, Vølund A, Madsbad S. The influence of GLP-1 on glucose-stimulated insulin secretion: Effects on beta-cell sensitivity in type 2 and nondiabetic subjects. Diabetes 2003;52:380-386
31. Sjaarda LG, Bacha F, Lee S, Tfayli H, Andreatta E, Arslanian S. Oral disposition index in obese youth from normal to prediabetes to diabetes: Relationship to clamp disposition index. J Pediatr 2012;161:51-57
32. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D Jr. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 1984;74:1318-1328
33. van der Zijl NJ, Goossens GH, Moors CC, et al. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: Impact on b-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab 2011;96: 459-467
34. Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 2002;51: 2796-2803
35. Mayer-Davis EJ, Monaco JH, Hoen HM, et al.; The Insulin Resistance Atherosclerosis Study (IRAS). Dietary fat and insulin sensitivity in a triethnic population: The role of obesity. Am J Clin Nutr 1997;65:79-87
36. Cobelli C, Toffolo GM, Dalla Man C, et al. Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab 2007;293:E1-E15
37. Utzschneider KM, Prigeon RL, Tong J, et al. Within-subject variability of measures of beta cell function derived from a 2 h OGTT: Implications for research studies. Diabetologia 2007; 50:2516-2525
38. Nauck MA, Blietz RW, Qualmann C. Comparison of hyperinsulinaemic clamp experiments using venous, 'arterialized' venous or capillary euglycaemia. Clin Physiol 1996;16: 589-602
39. Petrie JR, Ueda S, Morris AD, Elliott HL, Connell JM. Potential confounding effect of hand-warming on the measurement of insulin sensitivity. Clin Sci (Lond) 1996;91:65-71
40. Watanabe RM, Valle T, Hauser ER, et al. Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered 1999;49:159-168
41. Quon MJ, Cochran C, Taylor SI, Eastman RC. Non-insulin-mediated glucose disappearance in subjects with IDDM. Discordance between experimental results and minimal model analysis. Diabetes 1994;43:890-896
42. Pillonetto G, Sparacino G, Cobelli C. Numerical non-identifiability regions of the minimal model of glucose kinetics: Superiority of Bayesian estimation. Math Biosci 2003;184: 53-67
43. Pillonetto G, Sparacino G, Magni P, Bellazzi R, Cobelli C. Minimal model S(I)=0 problem in NIDDMsubjects: nonzero Bayesian estimates with credible confidence intervals. Am J Physiol Endocrinol Metab 2002;282:E564-E573
44. Dalla Man C, Pillonetto G, Riz M, Cobelli C. An index of parameter reproducibility accounting for estimation uncertainty: Theory and case study on b-cell responsivity and insulin sensitivity. Am J Physiol Endocrinol Metab 2015;308: E971-E977